A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)

Randwick

Parkville

Coburg, VIC

Fitzroy

Frankston

Greenslopes

Adelaide

Kurralta Park

Fremantle

Zhytomyr

Turin

Oswego

Syracuse

Oneida

Pittsburgh

Genoa

Cherkassy

Afula

Philadelphia

Rozzano

Milan

Milan

Bethesda

Bethesda

Randallstown

Baltimore

Cremona

Khmelnitskyy

Atlanta

Bay Pines

Poltava

Modena

Middletown

Lansing

Lansing

Dnipropetrovsk

Lille

Harvey

Tinley Park

Chicago

Decatur

Omaha

Pierre-Bénite

Shreverport

Ivano-Frankivsk

Rehovot

Corpus Christi

Lviv

Lubbock

Lubbock

Fort Collins

Donetsk

Farmington

Henderson

Las Vegas

Las Vegas

Reno

Los Angeles

Los Angeles

Los Angeles

Santa Monica

Duarte

Northridge

Burbank

Alhambra

La Jolla

San Luis Obispo

Pleasant Hill

Antioch

Dublin

Berkeley

Everett

Moscow

Petrozavodsk

Saint Petersburg

Ryazan

Kazan'

Petah Tikva

Ramat Gan

Los Angeles

San Leandro

Norwalk

Cherry Hill

Cachoeiro de Itapemirim

Belo Horizonte

Belo Horizonte

Rio de Janeiro

Caxias do Sul

Porto Alegre

Porto Alegre

Porto Alegre

Santo André

São Paulo

Brno

Hradec Králové

Prague

Chorzów

Gdansk

Warsaw

San Juan

Kyiv

Leicester

London